All Outputs (2)

Frequency, type and severity of drug-related problems and pharmacist interventions in Paxlovid prescribing: a descriptive analysis. (2024)
Journal Article
STOIBER, A., GRAY, G., SAILER, G., HUF, W. and TONNA, A. [2024]. Frequency, type and severity of drug-related problems and pharmacist interventions in Paxlovid prescribing: a descriptive analysis. International journal of clinical pharmacy [online], Latest Articles. Available from: https://doi.org/10.1007/s11096-024-01852-5

Paxlovid® (nirmatrelvir and ritonavir) is the only licensed oral antiviral for COVID-19. Ritonavir is a potent inhibitor of cytochrome P450 enzymes causing numerous drug-drug interactions (DDIs). The aim of this study was to describe the frequency, t... Read More about Frequency, type and severity of drug-related problems and pharmacist interventions in Paxlovid prescribing: a descriptive analysis..

Implementation of medication reviews in community pharmacy: reaching consensus on stakeholders' recommendations for mechanisms of change using the nominal group technique. (2024)
Journal Article
MICHEL, D.E., TONNA, A.P., DARTSCH, D.C. and WEIDMANN, A.E. 2024. Implementation of medication reviews in community pharmacy: reaching consensus on stakeholders’ recommendations for mechanisms of change using the nominal group technique. International journal of clinical pharmacy [online], 46(3), pages 714–726. Available from: https://doi.org/10.1007/s11096-024-01708-y

Since 2022, patients with five or more medicines are eligible for a medication review (MR) in a community pharmacy remunerated by the German health system. However, implementation has been slow, with few pharmacies providing MRs. Stakeholders' input... Read More about Implementation of medication reviews in community pharmacy: reaching consensus on stakeholders' recommendations for mechanisms of change using the nominal group technique..